logo-large
  • Browse Categories

Publications by authors named "Herbert Opitz"

Claim this Profile
P
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia.
Maria Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, John Porter, Thomas Coates, Herbert Opitz

Clin Ther· May 2007


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.
Antonio Piga, Renzo Galanello, Gian Luca Forni, Maria Domenica Cappellini, Raffaella Origa, Herbert Opitz

Haematologica· July 2006


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.
Maria Domenica Cappellini, Alan Cohen, Antonio Piga, Mohamed Bejaoui, Silverio Perrotta, Herbert Opitz

Blood· May 2006


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: